Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R.
Int J Mol Sci. 2021 May 29;22(11):5850. doi: 10.3390/ijms22115850.
The Diagnosis and Management of Neurofibromatosis Type 1.
Ly KI, Blakeley JO.
Med Clin North Am. 2019 Nov;103(6):1035-1054. doi: 10.1016/j.mcna.2019.07.004.
Neurofibromatosis type 1.
Cimino PJ, Gutmann DH.
Handb Clin Neurol. 2018;148:799-811. doi: 10.1016/B978-0-444-64076-5.00051-X.
Neurofibromatosis and Schwannomatosis.
Plotkin SR, Wick A.
Semin Neurol. 2018 Feb;38(1):73-85. doi: 10.1055/s-0038-1627471. Epub 2018 Mar 16.
Neurofibromatosis.
Korf BR.
Handb Clin Neurol. 2013;111:333-40. doi: 10.1016/B978-0-444-52891-9.00039-7.
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R.
Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31.
Neurofibromatosis.
Adeghate J, Tsang S, Sharma T.
Adv Exp Med Biol. 2025;1467:235-237. doi: 10.1007/978-3-031-72230-1_46.
Neurofibromatosis.
Goldberg NS.
Adv Dermatol. 1996;11:179-97; discussion 198.
Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations.
Goetsch Weisman A, Weiss McQuaid S, Radtke HB, Stoll J, Brown B, Gomes A.
Am J Med Genet A. 2023 Oct;191(10):2467-2481. doi: 10.1002/ajmg.a.63346. Epub 2023 Jul 24.
[Neurofibromatosis].
Wolkenstein P, Decq P.
Neurochirurgie. 1998 Nov;44(4):267-72.
